These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 22294181)

  • 1. Overview of drug discovery and development.
    Ator MA; Mallamo JP; Williams M
    Curr Protoc Pharmacol; 2006 Dec; Chapter 9():Unit9.9. PubMed ID: 22294181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failed Pediatric Drug Development Trials.
    Momper JD; Mulugeta Y; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):245-51. PubMed ID: 25963725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicology in the drug discovery and development process.
    Dorato MA; Buckley LA
    Curr Protoc Pharmacol; 2006 Apr; Chapter 10():Unit10.3. PubMed ID: 22294168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic chemistry in drug discovery.
    MacCoss M; Baillie TA
    Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems pharmacology to predict drug safety in drug development.
    Trame MN; Biliouris K; Lesko LJ; Mettetal JT
    Eur J Pharm Sci; 2016 Oct; 94():93-95. PubMed ID: 27251780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Drug Trials: The Path to the Patient.
    Diez Pascual C
    Methods Mol Biol; 2021; 2296():411-421. PubMed ID: 33977462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IND application.
    Ferkany JW; Williams M
    Curr Protoc Pharmacol; 2008 Sep; Chapter 9():Unit 9.10. PubMed ID: 22294234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is chemical synthetic accessibility computationally predictable for drug and lead-like molecules? A comparative assessment between medicinal and computational chemists.
    Bonnet P
    Eur J Med Chem; 2012 Aug; 54():679-89. PubMed ID: 22749644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building a drug development database: challenges in reliable data availability.
    Audibert C; Romine M; Caze A; Daniel G; Leff J; McClellan M
    Drug Dev Ind Pharm; 2017 Jan; 43(1):74-78. PubMed ID: 27494335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrocycles: MCR synthesis and applications in drug discovery.
    Abdelraheem EMM; Shaabani S; Dömling A
    Drug Discov Today Technol; 2018 Nov; 29():11-17. PubMed ID: 30471668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ligand efficiency and lead optimization].
    Guo ZR
    Yao Xue Xue Bao; 2013 Dec; 48(12):1755-62. PubMed ID: 24689231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Getting the dose right": facts, a blueprint, and encouragements.
    Peck CC; Cross JT
    Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068
    [No Abstract]   [Full Text] [Related]  

  • 13. Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology.
    Rostami-Hodjegan A
    Clin Pharmacol Ther; 2012 Jul; 92(1):50-61. PubMed ID: 22644330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical Advances in Medicinal Chemistry.
    Finn MG
    ACS Comb Sci; 2017 May; 19(5):277-278. PubMed ID: 28374995
    [No Abstract]   [Full Text] [Related]  

  • 15. De-risking drug discovery with ADDME -- avoiding drug development mistakes early.
    Tsaioun K; Jacewicz M
    Altern Lab Anim; 2009 Sep; 37 Suppl 1():47-55. PubMed ID: 19807206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we accelerate medicinal chemistry by augmenting the chemist with Big Data and artificial intelligence?
    Griffen EJ; Dossetter AG; Leach AG; Montague S
    Drug Discov Today; 2018 Jul; 23(7):1373-1384. PubMed ID: 29577971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development.
    Wang J; Avant D; Green D; Seo S; Fisher J; Mulberg AE; McCune SK; Burckart GJ
    Clin Pharmacol Ther; 2015 Sep; 98(3):328-35. PubMed ID: 25975723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of HT-ADME in drug discovery.
    Morgan D
    Bioanalysis; 2011 Nov; 3(21):2385-7. PubMed ID: 22074279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated pharmacokinetics and pharmacodynamics in drug development.
    Dingemanse J; Appel-Dingemanse S
    Clin Pharmacokinet; 2007; 46(9):713-37. PubMed ID: 17713971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.